Article

COPD Boosts Risk for Lung Cancer in Smokers

Author(s):

Patients diagnosed with small cell lung cancer have an average life expectancy of 14 to 20 months after diagnosis and results of a recent study show patients with chronic obstructive pulmonary disease who smoke are more likely than others to develop this deadly condition.

Chronic obstructive pulmonary disease (COPD) boosts the risk for smokers to get small cell lung cancer, according to findings published in EBioMedicine.

Researchers from Harvard School of Public Health reviewed 24 studies from the International Lung Cancer Consortium in order to determine how much COPD increases a smoker’s risk of getting small cell lung cancer. The researchers said that even though it is noted that smoking is obviously a major risk factor for lung cancer, the study is original in that it can estimate the risk more precisely than previously possible.

Small cell lung cancer is responsible for about one fifth of lung cancers worldwide, the researchers estimated, and patients have good responses to initial treatment. However, the patients often relapse within one year — typically surviving between 14 to 20 months after diagnosis.

The researchers retroactively examined more than 4,000 patients with small cell lung cancer and nearly 10 times that amount without the disease. Data on patients’ health, gender, age, race, education level, and family history of lung cancer was all collected. The researchers noted smoking status as well, including how old the patient was when they started smoking, how many cigarettes per day the patient was smoking, and how long it had been since the time a patient quit smoking, if they had accomplished smoking cessation.

The researchers found that smokers with COPD had a 1.86-fold higher risk of developing small cell lung cancer than smokers without COPD. In those smoking patients, having COPD accounted for 8% of small cell lung cancer cases.

“This work suggests that we need to tease out the mechanisms by which COPD may increase lung cancer risk in smokers, and to conduct clinical trials to determine whether treating COPD in former and current smokers lessens that risk,” senior author David Christiani, MD, MPH, MS, explained in a press release.

Additionally, for those patients who smoked one pack of cigarettes per day, the risk of getting small cell lung cancer spiked through 50 years of smoking. However, while the risk was still present after 50 smoking years, the risk was less dramatic. Compared to the almost 38,000 nonsmokers observed in the study, the odds for getting small cell lung cancer ranged from more than 4 times higher for those patients who smoked a pack a day for less than 2 decades to nearly 70 times higher than for those patients who smoked a pack a day for 80 years or more.

Related Videos
How to Manage Aspirin-Exacerbated Respiratory Disease
Safety Data on Dupilumab, Ensifentrine for COPD, with MeiLan Han, MD
MeiLan Han, MD: Discussing Updates on Dupilumab, Ensifentrine in 2025 GOLD Report
Christian Sadaka, MD: Significant Increase in Pediatric Gastroparesis Hospital Admissions After COVID-19
How Artificial Intelligence is Being Used in Lung Imaging, with Rachel Eddy, PhD
Developing Risk Assessment Tools for Viruses in School
Using Microbiomes to Diagnose Ventilator-Associated Pneumonia
What Do Patients Need to Learn About their Hypersensitivity Pneumonitis?
© 2024 MJH Life Sciences

All rights reserved.